|
CNBC'S MOST SHARED
- GM A Step Closer To Exiting Bankruptcy
- Farrell: Don't Head For The Exits Yet
- Obama's Russia Visit to Bring Over $1.5 Billion in Deals
- Lehman CEO: Firm Deserved Bailout or 'Wind Down'
- Bank of America Topples UBS as World Wealth Manager
- Data Domain Shares Up After EMC Raises Bid
- UBS Says It Stays Committed to US Brokerage
- Alcoa to Post Loss — What Does This Mean?
- A Goldman Trading Scandal?
- Is Andy’s Mojo Back? We Asked Him
- GM A Step Closer To Exiting Bankruptcy
- Schork Oil Outlook: The Fear Trade
- Market's Monday Blues
- Farrell: Don't Head For The Exits Yet
- Warren Buffett Lunch Winner: I Won't Profit From Stock Tip Windfall
- Go for Good Energy Companies: Bob Doll
- Yoshikami: A No Jobs Recovery Is Bad News
- Market 360: The Week's Best & Worst
The Dow Jones Industrial Average could sink as low as 6,700 before the year is out, in another accelerated down move similar to October's slump, Roelof van den Akker, chartist from ING Wholesale Banking, told CNBC.
"The price target for this year is still 6,700, so that's a lot of downside potential," Akker told "Squawk Box Europe."
Charts of the Dow show the "completion of a bearish pattern," which is "suggesting the same accelerated down move as back in October," Akker said.
The Dow [.DJIA
Loading...
()
] lost over 13 percent of its value in October. It closed at 8,273.58 on Monday, which is over 1,500 points higher than Akker's prediction for the year.
If the Dow closes below 8,175 then the next level of support for the index will be between 7,450 and 7,200, which were the October lows of 2002 and 2003, Akker said.
"The picture is bearish and we expect lower prices within the coming days and also weeks," he added.
(Watch the video above to see Akker's predictions for the DJ Euro Stoxx 50 and the euro.)
For the Investor:
Options Action: Dangerous Videogame Play
Cramer: Good Times or Bad, Some Things Work
Market Pros: Pharma M&A, Recession Cure Ahead
The Games Traders Play: Pump & Dump
How to Spot S&P 'Armageddon'
Best Trades Now: Biotech, Oil, Emerging Markets
Stock Picker: Stick with Big, Big Pharma








